ClinicalTrials.Veeva

Menu

Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation (Alster-Lost)

A

Asklepios proresearch

Status

Completed

Conditions

Atrial Fibrillation
Tachycardia

Treatments

Procedure: pulmonary vein isolation
Procedure: pulmonary vein isolation with additional ablation of fragmented potentials

Study type

Interventional

Funder types

Industry

Identifiers

NCT00820625
PV 2961 (Other Identifier)
1787

Details and patient eligibility

About

The chronic success rate, defined as freedom from any atrial tachyarrhythmias will increase from 35% to 60% by ablation of complex fragmented atrial electrograms potentials in addition to pulmonary vein isolation (PVI) as compared to PVI alone in patients with long-standing persistent AF.

Enrollment

124 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • long standing persistent atrial fibrillation > 6 months and < 5 years

Exclusion criteria

  • renal failure
  • left atrial size >55 mm

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

124 participants in 2 patient groups

1
Active Comparator group
Description:
ablation: pulmonary vein isolation
Treatment:
Procedure: pulmonary vein isolation
2
Active Comparator group
Description:
ablation: pulmonary vein isolation with additional ablation of fragmented potentials
Treatment:
Procedure: pulmonary vein isolation with additional ablation of fragmented potentials

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems